This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
TRILINK BIOTECHNOLOGIES LLC
TRILINK BIOTECHNOLOGIES LLC, headquartered in the United States, is a leading player in the biotechnology industry, specialising in nucleic acid synthesis and related services. Founded in 2000, the company has established itself as a trusted partner for researchers and organisations across the globe, with a strong operational presence in North America and Europe. TRILINK offers a diverse range of core products, including custom oligonucleotides, RNA synthesis, and modified nucleotides, all designed to meet the evolving needs of the scientific community. Their commitment to quality and innovation sets them apart, ensuring that clients receive superior products tailored to their specific applications. With a reputation for excellence, TRILINK has achieved significant milestones, solidifying its position as a preferred supplier in the biotechnology sector.
DitchCarbon Score
How does TRILINK BIOTECHNOLOGIES LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
TRILINK BIOTECHNOLOGIES LLC's score of 29 is higher than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
TriLink BioTechnologies LLC, headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Maravai LifeSciences Holdings, Inc., which may influence its climate commitments and reporting practices. As of now, TriLink BioTechnologies has not established any documented reduction targets or climate pledges. The lack of specific emissions data and reduction initiatives suggests that the company may still be in the early stages of developing a comprehensive climate strategy. Given its affiliation with Maravai LifeSciences, any potential climate commitments or emissions data may be inherited from this parent company. However, no specific details regarding emissions or reduction targets from Maravai LifeSciences have been provided in the available data. In summary, while TriLink BioTechnologies LLC has not disclosed any emissions data or reduction initiatives, its relationship with Maravai LifeSciences may play a role in shaping its future climate commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 330,000 | 000,000 | 000,000 | 000,000 |
| Scope 2 | 1,103,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
TRILINK BIOTECHNOLOGIES LLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
